SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending amid intense investor euphoria and a massive short squeeze, with the community actively debating whether the stock's parabolic ascentdriven by aggressive price target hikes and AI infrastructure demandis a sustainable supercycle or a speculative bubble destined for a sharp correction. Traders are locked in a fierce tug-of-war, with bulls pointing to fundamental memory storage needs while bears focus on the stock's extreme year-over-year gains and the potential for a blow-off top.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is currently a focal point for investors as the company undergoes significant restructuring, including widespread layoffs, to fund an aggressive pivot toward AI-driven data center expansion. While some in the community view these moves as a strategic reallocation of capital to secure long-term growth, many investors are expressing frustration over the stock's persistent downward trend and volatility compared to broader market gains.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently under pressure as traders react to a now-deleted claim by investor Michael Burry that rival Anthropic is disrupting the company's business model. While community sentiment is heavily polarized between long-term supporters defending the stock's fundamental moat and bears pointing to its high valuation and competition, the stock is seeing significant volatility as investors weigh the impact of these narratives ahead of upcoming earnings.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as a major beneficiary of sector-wide capital rotation, fueled by strategic collaborations with Google and the Terafab project involving Tesla and SpaceX. The community is actively debating whether this momentum marks a sustainable turnaround for the foundry business or a temporary sentiment-driven rally.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as it faces heavy selling pressure alongside the broader SaaS sector, driven by analyst downgrades and growing market anxiety that agentic AI models could disrupt traditional subscription-based enterprise software. Despite solid fundamentals and management's confidence, the community is deeply divided between those viewing the decline as a generational buying opportunity and those fearing a long-term structural shift away from legacy platforms.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following the announcement of a massive $21 billion multi-year deal with Meta, alongside a $3 billion convertible note offering to fund rapid AI infrastructure expansion. The community is actively debating the trade-off between this aggressive, debt-fueled growth strategy and the potential for long-term dominance in the AI cloud sector, with many investors closely watching if the stock can overcome short-term dilution fears and resistance levels to regain triple-digit pricing.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is trending as investors react to the FDA accepting the BLA resubmission for its melanoma treatment, with a PDUFA date set for April 2026. The community is actively debating the likelihood of approval following a prior Complete Response Letter, with many analyzing whether the resubmitted data sufficiently addresses previous concerns regarding trial design and efficacy.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as record-breaking Q1 revenue and strong monthly sales confirm that AI infrastructure demand remains robust, effectively silencing concerns about a cooling cycle. The community is actively discussing the stock's role as a reliable 'lie detector' for the semiconductor industry, with investors closely watching capacity expansion and aggressive analyst price target hikes as bullish indicators despite ongoing geopolitical and supply-chain uncertainties.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon & Co. is currently the subject of intense speculation as buyout rumors, particularly involving potential interest from Sun Pharma, fuel volatility alongside ongoing discussions about the company's significant debt load. While some investors are betting on a turnaround driven by the recent FDA approval for Nexplanon's extended use and VTAMA trial success, others remain cautious, debating whether the stock is a deep-value opportunity or a long-term play burdened by its balance sheet.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is currently at the center of a intense tug-of-war as investors weigh weak quarterly revenue and EPS against a massive surge in bookings and an optimistic outlook driven by AI-related demand. While the community is sharply divided between those betting on a potential short squeeze fueled by record backlog and others warning of a major valuation correction, the stock remains a high-volatility battleground for those tracking the broader photonics and semiconductor testing supercycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Analysts

Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have received a consensus rating of "Hold" from the five research firms that are covering the firm, MarketBeat Ratings reports. One...

Q1 Earnings Forecast for HRTX Issued By Northland Securities

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Northland Securities cut their Q1 2026 EPS estimates for Heron Therapeutics in a research note issued to investors on Thursday, March 26th...

What is Northland Securities' Estimate for HRTX Q3 Earnings?

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at Northland Securities upped their Q3 2026 earnings estimates for shares of Heron Therapeutics in a research note...

Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX

Baker BROS. Advisors LP purchased a new stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...

Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX

Citigroup Inc. boosted its position in Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 4,666.9% during the third quarter, according to the company in its most recent filing with the...

HC Wainwright Has Negative Forecast for HRTX FY2026 Earnings

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 earnings per share (EPS) estimates for Heron Therapeutics in a research note...

What is Northland Securities' Forecast for HRTX Q1 Earnings?

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Northland Securities issued their Q1 2026 earnings per share (EPS) estimates for Heron Therapeutics in a research report issued on Thursday...

Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to Strong Sell at Zacks Research

Zacks Research lowered Heron Therapeutics from a "hold" rating to a "strong sell" rating in a research note on Thursday...

What is HC Wainwright's Estimate for HRTX Q1 Earnings?

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 EPS estimates for shares of Heron Therapeutics in a research report issued to clients...

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Current Price	$0.8194
Prev Close	$0.832
Open	$0.8256
Dividend Yield	0.00%
50-Day Moving Average	$1.04
Beta	1.45
Avg. Volume	2.06M
PE Ratio	-6.80

52-Week High	$2.61
52-Week Low	$0.7362
Market Capitalization	$154.49M
EPS (Annual)	-$0.1211
Price to Book	11.62
Revenue Per Employee	$1.21M

HRTX
Heron Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HRTX News

HRTXHeron Therapeutics Inc